Tag: Albert Bourla

Health Care, Industry

COVID antiviral Paxlovid to see price increase following 400% vaccine hike

October 18, 2023

Via: ArsTechnica

After raising the price of COVID-19 vaccines more than fourfold this year, Pfizer CEO Albert Bourla told investors Monday that the company will also likely hike the price of its lifesaving COVID-19 antiviral treatment, Paxlovid, raising further concern about access […]